Amblyopia Treatment for Children Aged 8 to 12 Years
Retina Foundation of the Southwest · NCT07281742
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 8–12 · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 30
- US sites recruiting
- 1
- Study start
- January 7, 2025
- Record last updated
- December 15, 2025
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
This study is being done to assess the effect of at-home amblyopia treatment with Curesight™ for children aged 8 to 12 years. Curesight™ allows you to stream any videos on a computer screen at home but the amblyopic eye will see the entire screen clearly while part of the image will be blurred for the other eye. There is already a pivotal clinical trial showing that this treatment is effective for young children and Curesight™ has been cleared for use as an amblyopia treatment by the FDA for children as young as 4 years.
Being studied: Curesight dichoptic videos
Conditions: Amblyopia
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Female and male children with amblyopia age 8-12 years inclusive
- Amblyopic eye visual acuity ≤ 1.0 logMar (20/32-20/200)
- Interocular difference in visual acuity of 0.3 logMAR or more
- Anisometropia or strabismus corrected to \<5 pd
- Wearing glasses (if needed) ≥8 weeks
- No longer using standard-of-care treatments for amblyopia
- Informed consent
Exclusion Criteria
- Prematurity >8 weeks
- Coexisting ocular or systemic disease
- Developmental delay
- History of light-induced epilepsy
- Eye conditions that interfere with eye tracking (nystagmus, wearing RGP contact lenses, paralysis of the extra ocular muscles or any neurological condition that restricts eye movements, ptosis that covers the pupil)
Recruiting US locations
Retina Foundation of the Southwest
Dallas, TX 75231
Site contact: Eileen CEO · 214-363-3911 · kcsaky@retinafoundation.org
Study contacts (from the official record)
- Eileen E Birch, PhD · 12144771464 · ebirch@retinafoundation.org
- Reed M Jost, MS · 2143633911 · reedjost@retinafoundation.org
Similar studies in Texas
All healthy volunteers studies in Texas →- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
A Study of LY4355756 in Healthy Participants
Eli Lilly and Company
- Location
- Dallas, TX
- Eligibility basics
- Ages 18–65
- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
A Phase I Study to Investigate the Pharmacokinetics and Safety of Capivasertib in Participants With Moderate Hepatic Impairment
AstraZeneca
- Location
- San Antonio, TX + 1 other US site
- Eligibility basics
- Ages 18–80
- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight
Eli Lilly and Company
- Location
- San Antonio, TX
- Eligibility basics
- Ages 18–65
- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
Radiprodil in Participants With Hepatic Impairment
GRIN Therapeutics, Inc.
- Location
- DeSoto, TX + 1 other US site
- Eligibility basics
- Ages 18–75